| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $106.5M | +123.2% | +158.9% |
| R&D Expense | $21.9M | — | -20.0% |
| SG&A Expense | $12.0M | — | -50.4% |
| Operating Income | $72.6M | — | +349.3% |
| Pre-tax Income | $65.2M | — | +279.7% |
| Income Tax | $24.4M | — | +2090.2% |
| Net Income | $40.8M | +1891.4% | +209.1% |
| EPS (Basic) | $0.25 | +2600.0% | +208.7% |
| EPS (Diluted) | $0.24 | +2500.0% | +204.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $220.5M | +2.3% | +103.2% |
| Accounts Receivable | $105.8M | +126.4% | +166.1% |
| Current Assets | $332.3M | +21.2% | +106.9% |
| Total Assets | $434.6M | +9.5% | +32.8% |
| Current Liabilities | $236.3M | -2.4% | +391.3% |
| Stockholders' Equity | -$217.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.1M | — | -74.3% |
| Capital Expenditures | $31K | — | +0.0% |
| Investing Cash Flow | -$31K | — | +0.0% |
| Financing Cash Flow | $6K | — | +0.0% |
| Free Cash Flow | $5.1M | — | -74.5% |
| +35.0% |